BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2019
View Archived Issues
Safety and efficacy of autologous gene therapy after busulfan conditioning in infants with SCID-X1
Read More
Pharmacological modulation of sigma 2 receptor shows in vivo neuroprotective effect after TBI
Read More
Development of a new animal model of acute-on-chronic liver failure
Read More
TCF20 deficiency tied to liver fibrosis in animal models
Read More
Trigger region found for absence epileptic seizures
Read More
Discovery and optimization of novel STING agonist for the treatment of cancer
Read More
UCB-9260 demonstrates promising activity in TNF-alpha-driven mouse model
Read More
First patient enrolled in proof-of-concept study of ATH-3G10 in heart failure
Read More
FDA lifts partial clinical hold on phase I study of XmAb-14045
Read More
Phase IIa study of BIV-201 in refractory ascites meets primary objectives
Read More
Preclinical results presented for Ad5-3M in the treatment of solid and disseminated tumors
Read More
Gel-B prevents hepatic steatosis in HFD-induced NAFLD in vivo
Read More
Soluble MAdCAM-1 as a novel marker of endothelial activation in decompensated cirrhosis
Read More
Exonate presents SRPK1 inhibitor EXN-407
Read More
Innovatives Molecules describes new antiviral compounds
Read More
FORMA Therapeutics identifies new histone deacetylase 6 inhibitors
Read More
New phase II trial investigates BPN-14770 in early Alzheimer's disease
Read More
FDA approves Dengvaxia for prevention of dengue infection in endemic areas
Read More
Shanghai Institute of Materia Medica discloses new antibacterials
Read More
Bristol-Myers Squibb patents IDO-1 inhibitors
Read More
Merck & Co. describes new LRRK2 inhibitors
Read More
MCT 4 lactate transporter inhibitor AZD-0095 targets immunosuppression in tumors
Read More
NexImmune and MMRF partner to advance NEXI-002 for multiple myeloma
Read More
Genkyotex reports topline phase II data for GKT-831 in primary biliary cholangitis
Read More
FDA issues complete response letter for HTX-011 for postoperative pain
Read More
Checkpoint Therapeutics reports interim data from phase I trial of cosibelimab
Read More
FDA approves Mavyret for pediatric patients with HCV
Read More
European Commission approves Skyrizi for plaque psoriasis
Read More
Phase I study of CVN-424 for Parkinson's demonstrates safety in healthy subjects
Read More
Kalydeco approved in U.S. for infants from 6 months with cystic fibrosis
Read More
FDA issues complete response letter for Contepo for complicated urinary tract infections
Read More
3-V Biosciences initiates phase II trial of TVB-2640 in NASH
Read More
